A crowd of more than a thousand marched from Boston Common to the JFK Federal Building in protest of the Trump administration ...

Moderna Inc.’s stock erased early losses to gain 3.4% on Friday, after the biotech company posted a wider-than-expected ...

A Boston developer won planning-board approval for his third office-to-housing conversion under a city tax-break program.

The biotech giant reported a bigger-than-expected quarterly loss. Finance chief James Mock attributed the loss to a scale down.

The company’s earnings update initially discouraged investors, who traded the stock down as much as 8.4% when the market opened Friday. The shares later rallied, gaining as much as 6.2%, amid broader ...

The leader of Breaktime, a homelessness nonprofit, engineered a $6 million deal to purchase a five-story building.

Boston Scientific stock jumped Wednesday after the medtech giant easily beat Wall Street's fourth-quarter expectations and ...

WASHINGTON — (AP) — President Donald Trump's new tool for reshaping the federal government is a relatively obscure agency, the Office of Personnel Management. The agency has offered millions of ...

A Suffolk County judge dismissed a lawsuit from a former state employee who claimed officials at the State Auditor’s Office forced ... to relief.’” Boston ICE veteran to lead nation ...

The American pharmaceutical company Moderna is developing an mRNA-based vaccine candidate for norovirus, designated as mRNA-1403. This vaccine is designed to protect against multiple norovirus ...

Moderna (NASDAQ:MRNA) was among the notable gainers on Wednesday after Oracle (NYSE:ORCL) Chairman Larry Ellison highlighted the AI's potential in the development of messenger RNA-based cancer ...